Nanoparticle‐microglial interaction in the ischemic brain is modulated by injury duration and treatment

Cerebral ischemia is a major cause of death in both neonates and adults, and currently has no cure. Nanotechnology represents one promising area of therapeutic development for cerebral ischemia due to the ability of nanoparticles to overcome biological barriers in the brain. ex vivo injury models ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Andrea, Liao, Rick, Zhang, Mengying, Helmbrecht, Hawley, McKenna, Michael, Filteau, Jeremy R., Nance, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510458/
https://www.ncbi.nlm.nih.gov/pubmed/33005740
http://dx.doi.org/10.1002/btm2.10175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510458/
https://www.ncbi.nlm.nih.gov/pubmed/33005740
http://dx.doi.org/10.1002/btm2.10175

Ejemplares similares